Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
After withdrawing its filing last year, ImaRx Therapeutics (pharmaceuticals for cardiovascular conditions) has now gone public through an IPO netting $12.3mm through the sale of 3mm common shares at $5 each; the company originally estimated a share price in the $6.50-7.50 range.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?